Coloplast Financials
| COLO-B Stock | DKK 786.20 2.40 0.31% |
Coloplast |
Understanding current and past Coloplast Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Coloplast's financial statements are interrelated, with each one affecting the others. For example, an increase in Coloplast's assets may result in an increase in income on the income statement.
Please note, the presentation of Coloplast's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Coloplast's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Coloplast's management manipulating its earnings.
Coloplast Stock Summary
Coloplast competes with DSV Panalpina, GN Store, and Ambu AS. Coloplast AS develops and markets intimate healthcare products and services worldwide. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast operates under Healthcare Products classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 12000 people.| Instrument | Denmark Stock View All |
| Exchange | Copenhagen Exchange |
| ISIN | DK0060448595 |
| Business Address | Holtedam 1-3, Humlebk, |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.coloplast.com |
| Phone | 45 49 11 11 11 |
| Currency | DKK - Danish Krone |
You should never invest in Coloplast without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Coloplast Stock, because this is throwing your money away. Analyzing the key information contained in Coloplast's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Coloplast Key Financial Ratios
Coloplast's financial ratios allow both analysts and investors to convert raw data from Coloplast's financial statements into concise, actionable information that can be used to evaluate the performance of Coloplast over time and compare it to other companies across industries.| Return On Equity | 0.75 | |||
| Return On Asset | 0.17 | |||
| Target Price | 954.18 | |||
| Beta | 0.21 | |||
| Z Score | 6.0 |
Coloplast Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Coloplast's current stock value. Our valuation model uses many indicators to compare Coloplast value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Coloplast competition to find correlations between indicators driving Coloplast's intrinsic value. More Info.Coloplast AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.23 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Coloplast AS is roughly 4.38 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Coloplast by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Coloplast's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Coloplast AS Systematic Risk
Coloplast's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Coloplast volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Coloplast AS correlated with the market. If Beta is less than 0 Coloplast generally moves in the opposite direction as compared to the market. If Coloplast Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Coloplast AS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Coloplast is generally in the same direction as the market. If Beta > 1 Coloplast moves generally in the same direction as, but more than the movement of the benchmark.
Coloplast February 8, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Coloplast help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Coloplast AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Coloplast AS based on widely used predictive technical indicators. In general, we focus on analyzing Coloplast Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Coloplast's daily price indicators and compare them against related drivers.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 6.72 | |||
| Value At Risk | (2.05) | |||
| Potential Upside | 1.93 |
Complementary Tools for Coloplast Stock analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |